Companies

Neurogene Inc. (NGNE) SEC filings

CIK 0001404644 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)00
Net income (USD)-55.2 M-60.7 M
Diluted EPS (USD/shares)-4.24-1.04

Latest filings

FiledFormDescriptionPeriod
2026-10-07SCHEDULE 13GSCHEDULE 13G
2026-10-06SCHEDULE 13GSCHEDULE 13G
2026-10-024FORM 42026-09-22
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13GSCHEDULE 13G
2026-08-1110-Q10-Q2026-06-30
2026-08-118-K8-K items 2.02,9.012026-08-11
2026-07-074FORM 42026-07-06
2026-07-024FORM 42026-07-01
2026-07-028-K8-K items 1.01,8.01,9.012026-06-30
2026-07-02424B5424B5
2026-06-30424B5424B5
2026-06-298-K8-K items 7.01,8.01,9.012026-06-29
2026-06-164/AFORM 4/A2024-01-16
2026-06-164/AFORM 4/A2024-06-14
2026-06-164/AFORM 4/A2025-06-12
2026-06-163/AFORM 3/A2023-12-18
2026-06-088-K8-K items 7.01,9.012026-06-08
2026-06-048-K8-K items 5.072026-06-03
2026-05-128-K8-K items 2.02,9.012026-05-12
2026-05-1210-Q10-Q2026-03-31
2026-05-084FORM 42026-05-06
2026-05-074FORM 42026-05-05
2026-05-06144144

Forms on file (last 1,000): 4 232, 8-K 148, 3 44, 10-Q 38, SC 13G/A 38, SC 13G 36, SC 13D/A 17, S-8 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=NGNE (0.002 USD), /gw/filings/filings?ticker=NGNE&form=8-K, /gw/filings/facts?ticker=NGNE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange